Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
clinical trials
life sciences
2
×
national blog main
antisense oligonucleotide
benzodiazepines
biogen
biotech
blackstone group
blackstone life sciences
boston
boston blog main
boston top stories
cannabidiol
columbia university
david goldstein
depression
dravet syndrome
drugs
epi4k
epidiolex
epilepsy
essential tremor
fda
fen-phen
fenfluramine
gw pharmaceuticals
investing
kiran reddy
lennox-gastaut syndrome
major depressive disorder
marcio souza
national top stories
new york blog main
new york top stories
perimenopausal depression
praxis precision medicines
ptc therapeutics
san francisco
san francisco blog main
san francisco top stories
What
epilepsy
2
×
ago
aims
approved
backed
battle
cannabis
cause
ceo
data
derivative
drug
drugs
fda
form
genes
genetic
gw
gw’s
links
marcio
marijuana
market
medicine
medicines
mutations
neuro
new
pharmaceuticals
praxis
precision
rare
research
sets
souza
stop
turn
weeks
zogenix
Language
unset
Current search:
epilepsy
×
photo
×
" life sciences "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
